Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cesca Therapeutics (KOOL)

Cesca Therapeutics (KOOL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,420
  • Shares Outstanding, K 2,416
  • Annual Sales, $ 9,670 K
  • Annual Income, $ -39,720 K
  • 60-Month Beta 1.07
  • Price/Sales 1.20
  • Price/Cash Flow N/A
  • Price/Book 1.87
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.57
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +90.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.18 +22.97%
on 10/25/19
6.90 -25.50%
on 10/01/19
-1.49 (-22.47%)
since 09/30/19
3-Month
2.60 +97.69%
on 08/14/19
7.00 -26.57%
on 09/27/19
+2.22 (+76.03%)
since 07/30/19
52-Week
2.10 +144.76%
on 12/24/18
7.00 -26.57%
on 09/27/19
+2.34 (+83.57%)
since 10/30/18

Most Recent Stories

More News
Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis")...

KOOL : 5.14 (+7.31%)
Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu, Ph.D., Chairman and Chief Executive...

KOOL : 5.14 (+7.31%)
Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today...

KOOL : 5.14 (+7.31%)
Cesca Therapeutics To Present At The 2019 Bio Investor Forum

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that Jeff Cauble, Vice President of Finance...

KOOL : 5.14 (+7.31%)
Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the...

KOOL : 5.14 (+7.31%)
Small Caps Win in September: 5 Best ETFs & Stocks

We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.

HOV : 21.23 (-1.58%)
RWJ : 64.41 (-0.31%)
PSCM : 45.15 (+0.73%)
RZV : 65.76 (-0.27%)
KOOL : 5.14 (+7.31%)
LXRX : 4.05 (+1.00%)
MCF : 3.06 (+4.44%)
YI : 5.03 (-2.90%)
XSVM : 32.07 (-0.12%)
XSHD : 23.74 (-0.50%)
ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the...

KOOL : 5.14 (+7.31%)
Accelerate Diagnostics (AXDX) Jumps: Stock Rises 9.4%

Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

AXDX : 16.24 (-0.79%)
KOOL : 5.14 (+7.31%)
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the...

KOOL : 5.14 (+7.31%)
Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Jeff Cauble, Vice President of Finance and...

KOOL : 5.14 (+7.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

The current trending strength of the market is Good.

Long term indicators fully support a continuation of the trend.

See More Share

Trade KOOL with:

Business Summary

Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation,...

See More

Key Turning Points

2nd Resistance Point 5.45
1st Resistance Point 5.29
Last Price 5.14
1st Support Level 4.89
2nd Support Level 4.65

See More

52-Week High 7.00
Last Price 5.14
Fibonacci 61.8% 5.13
Fibonacci 50% 4.55
Fibonacci 38.2% 3.97
52-Week Low 2.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar